iTechGuides is reader-supported. When you buy through links on our site, we may earn an affiliate commission. As an Amazon Associate I earn from qualifying purchases. Learn more
Some cancers are increasingly diagnosed in younger adults, but the evidence does not show that everyone has a higher chance of cancer before 50 than their parents did. The clearest global headline is an increase in the number of cases—not a 79.1% increase in an individual’s risk—and trends vary by cancer, age group and population.
What the global figures actually show
A 2023 analysis in BMJ Oncology used Global Burden of Disease 2019 data to examine 29 cancer groups. It estimated 3.26 million early-onset cases in 2019 and reported that the number of cases rose 79.1% between 1990 and 2019. The same analysis found a 27.7% increase in the number of early-onset cancer deaths over that period.
In this analysis, “early-onset” refers to cancer diagnosed before age 50. The percentages describe changes in totals, not the percentage change in a person’s chance of developing cancer. Total case counts can rise as populations grow or their age structures change; they do not, on their own, establish how an individual’s age-specific or age-standardized risk changed.
Outdated Drivers Are Slowing You Down
One free scan finds every outdated or missing driver and matches the right update for your exact hardware.Free scan · exact hardware matchWindows Errors? Fix Them Before They Spread
Repair common Windows errors and clear accumulated junk for a smoother, more stable PC - no reinstall needed.Free scan · no reinstallThe figures also cover a defined set of cancers and data ending in 2019. They are not a count of cases in 2026, and they should not be read as a forecast or as a direct comparison between you and your own parents.
#1 Best Overall
Why the answer changes by country, cancer and age
“Cancer in younger people” is not one uniform trend. Results depend on which cancer sites are included, the age band used, the country studied, the years covered and whether a study measures new diagnoses or deaths. Early-onset cancer commonly means diagnosis before 50 in the cited work, but definitions and study populations can differ.
A 2025 National Cancer Institute (NCI) analysis assessed 33 cancer types in the United States, using incidence data from 2010–2019 and mortality data from 2010–2022. NCI describes the trends as differing by cancer and age group. Those US findings cannot be substituted for a global measure, and their incidence and mortality periods are not identical.
Rank #2
- Incidence counts new diagnoses. It can be affected by how often people are screened, how cancers are detected, diagnostic practice and coding, as well as by how often disease occurs.
- Mortality counts deaths. It is a different outcome from diagnosis and cannot be inferred from an increase in case counts.
- Counts and rates answer different questions. Counts show how many cases occurred; rates are needed to compare occurrence relative to population size and, when age-standardized, to account for differences in age structure.
So the evidence supports concern about rising diagnoses in some younger populations, not a blanket claim that every cancer is rising among all younger adults or that every person is more likely to get cancer than a parent.
What may be driving the changes—and what is still unknown
There is no demonstrated single cause for the overall pattern. Meredith Shiels, Ph.D., the lead investigator on the NCI study, said: “The causes of these increases are likely to be cancer specific, including cancer risk factors becoming more common at younger ages, changes in cancer screening or detection, and updates to clinical diagnosis or coding of cancers.” These are possible explanations to investigate, not proof that one factor explains the trend across cancers.
Working out whether a change reflects more underlying disease, earlier or more frequent detection, or changes in classification requires evidence tied to a specific cancer, population and time period. The global analysis called for prospective life-course cohort research: studies that follow people over time and can examine exposures and health outcomes across stages of life. Without that kind of evidence, proposed explanations should remain hypotheses rather than a universal answer to “what went wrong?”
Independent reader supportYour contribution helps us test, update, and keep practical guides available for everyone.What this means for you
Population-level trends cannot tell an individual whether a symptom is cancer or predict their personal risk. Take persistent or concerning symptoms seriously and seek advice from a qualified health professional; a trend headline is not a diagnosis. These findings also do not establish that a consumer product, supplement or screening kit is a general solution to the rise in early-onset cancer.
Quick Recap
Best Value
- New York Times Bestseller “This book may help those who are susceptible to illnesses that can be prevented.” ―His Holiness the Dalai Lama “Absolutely the best book I’ve read on nutrition and diet” –Dan Buettner, author of The Blue Zones Solution
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
Recommended Free Tools
